CUE vs PANW · rev $9.3M vs P/E 245, rev $9.22B
Cue Biopharma (CUE) versus Palo Alto Networks Inc (PANW) — a side-by-side from cached financials, not a winner call.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Palo Alto Networks Inc (PANW) is a software - infrastructure company listed on NASDAQ. It is led by Nikesh Arora.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
Latest reported PANW revenue for 2025-07-31 was $9.22B. Net income was $1.13B. PANW currently screens at market cap $229.94B and trailing P/E 245.3.
CUE currently screens at market cap $59.5M. PANW currently screens at market cap $229.94B and trailing P/E 245.3.
Not investment advice. Open the CUE and PANW stock pages for the full models.
Not investment advice.